Qsymia Safety: New Research About Cardiovascular Risk
VIVUS Inc. – the manufacturer of Qsymia weight loss pills – released a press release on Monday that announced the results of a promising retroactive study on Qsymia safety. Authors concluded that the risk of major adverse cardiovascular events, such as heart attack and stroke, is lower when taking Qsymia, generic phentermine & topiramate (combined),…
End of content
End of content